Register entryShortage reported
- Registered sites
- 0
- Active NDC listings
- 32
- Live patents
- 0
- Shortage listings
- 7
- Countries
- 0
Alert
Drug shortage listings
7| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Promethazine Hydrochloride InjectionAnalgesia/Addiction, Gastroenterology, Other, Pulmonary/Allergy | Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6) | Current | Unvailable | 21 Nov 202322 Sept 2026 |
| Promethazine Hydrochloride InjectionAnalgesia/Addiction, Gastroenterology, Other, Pulmonary/Allergy | Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3) | Current | Available | 21 Nov 202322 Sept 2026 |
| Rocuronium Bromide InjectionAnesthesia | Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2) | Current | Available | 15 Feb 202322 Sept 2026 |
| Rocuronium Bromide InjectionAnesthesia | Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6) | Current | Available | 15 Feb 202322 Sept 2026 |
| Lincomycin Hydrochloride InjectionAnti-Infective | Lincomycin Hydrochloride, Injection, 3 grams/10 mL vial x 10 count (NDC 39822-0355-6) | To Be Discontinued | - | 26 Mar 202626 Mar 2026 |
| Lincomycin Hydrochloride InjectionAnti-Infective | Lincomycin Hydrochloride, Injection, 600 mg/2 mL vial x 10 count (NDC 39822-0350-2) | To Be Discontinued | - | 26 Mar 202626 Mar 2026 |
| Pentamidine Isethionate InjectionAnti-Infective | Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2) | To Be Discontinued | - | 23 Mar 202623 Mar 2026 |
Catalogue
Drug listings by form and route
3232 active NDC listings: 32 human prescription drug. By marketing category: ANDA 32.
| Dosage form | NDCs |
|---|---|
| injection, solution | 12 |
| injection, powder, lyophilized, for solution | 11 |
| solution | 4 |
| injection | 2 |
| inhalant | 1 |
| injection, powder, for solution | 1 |
| injection, solution, concentrate | 1 |
| Route | NDCs |
|---|---|
| intravenous | 24 |
| intramuscular | 8 |
| oral | 3 |
| subcutaneous | 3 |
| epidural | 2 |
| irrigation | 2 |
| subconjunctival | 2 |
| percutaneous | 1 |
| respiratory (inhalation) | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| xgen pharmaceuticals djb, inc. | 32 |
Catalogue
Marketed products
33Showing 32 of 33.
| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Acetazolamide | Acetazolamide | injection, powder, lyophilized, for solution, intravenous | 39822-0190ANDA |
| Amphotericin B | Amphotericin B | injection, powder, lyophilized, for solution, intravenous | 39822-1055ANDA |
| CYCLOPHOSPHAMIDE | Cyclophosphamide | injection, powder, lyophilized, for solution, intravenous, oral | 39822-0250ANDA |
| CYCLOPHOSPHAMIDE | Cyclophosphamide | injection, powder, lyophilized, for solution, intravenous, oral | 39822-0255ANDA |
| CYCLOPHOSPHAMIDE | Cyclophosphamide | injection, powder, lyophilized, for solution, intravenous, oral | 39822-0260ANDA |
| Clonidine | Clonidine | injection, solution, epidural | 39822-2000ANDA |
| Clonidine | Clonidine | injection, solution, epidural | 39822-2010ANDA |
| Dehydrated Alcohol | Alcohol | injection, solution, percutaneous | 39822-9300ANDA |
| Desmopressin Acetate | desmopressin acetate | injection, solution, intravenous, subcutaneous | 39822-6200ANDA |
| Desmopressin Acetate | desmopressin acetate | injection, solution, intravenous, subcutaneous | 39822-6250ANDA |
| ERIBULIN MESYLATE | eribulin mesylate | injection, intravenous | 39822-2080ANDA |
| Folic Acid | Folic Acid | injection, solution, intramuscular, intravenous, subcutaneous | 39822-1100ANDA |
| Ibuprofen Lysine | Ibuprofen Lysine | solution, intravenous | 39822-1030ANDA |
| Levetiracetam | Levetiracetam | injection, solution, concentrate, intravenous | 39822-4000ANDA |
| Lincomycin | lincomycin hydrochloride | injection, solution, intramuscular, intravenous, subconjunctival | 39822-0350ANDA |
| Lincomycin | lincomycin hydrochloride | injection, solution, intramuscular, intravenous, subconjunctival | 39822-0353ANDA |
| Liothyronine Sodium | Liothyronine Sodium | injection, solution, intravenous | 39822-0151ANDA |
| Nelarabine | Nelarabine | injection, intravenous | 39822-0650ANDA |
| Neomycin and Polymyxin B Sulfates | Neomycin and Polymyxin B Sulfates | solution, irrigation | 39822-1201ANDA |
| Neomycin and Polymyxin B Sulfates | Neomycin and Polymyxin B Sulfates | solution, irrigation | 39822-1220ANDA |
| Olanzapine | Olanzapine | injection, powder, for solution, intramuscular | 39822-1800ANDA |
| PENTAMIDINE ISETHIONATE | PENTAMIDINE ISETHIONATE | injection, powder, lyophilized, for solution, intramuscular, intravenous | 39822-3050ANDA |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | injection, solution, intramuscular, intravenous | 39822-5525ANDA |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | injection, solution, intramuscular, intravenous | 39822-5550ANDA |
| Pentamidine Isethionate | PENTAMIDINE ISETHIONATE | inhalant, respiratory (inhalation) | 39822-3030ANDA |
| Streptomycin | Streptomycin | injection, powder, lyophilized, for solution, intramuscular | 39822-0706ANDA |
| Tobramycin | Tobramycin | injection, powder, lyophilized, for solution, intravenous | 39822-0412ANDA |
| Tranexamic Acid | Tranexamic Acid | injection, solution, intravenous | 39822-1000ANDA |
| Vancomycin Hydrochloride | Vancomycin Hydrochloride | injection, powder, lyophilized, for solution, intravenous | 39822-0460ANDA |
| Vancomycin Hydrochloride | Vancomycin Hydrochloride | injection, powder, lyophilized, for solution, intravenous | 39822-0470ANDA |
| dactinomycin | dactinomycin | injection, powder, lyophilized, for solution, intravenous | 39822-2100ANDA |
| rocuronium bromide | rocuronium bromide | solution, intravenous | 39822-4200ANDA |
Compare
Other companies listing cyclophosphamide
- Baxter Healthcare Corporation16 sites · 416 NDC
- Hetero Labs Limited8 sites · 167 NDC
- Piramal Healthcare (Canada) Limited8 sites · 86 NDC
- Alembic Pharmaceuticals Limited7 sites · 998 NDC
- CIPLA PHARMACEUTICALS LIMITED7 sites · 368 NDC
- Sandoz Industrial Products S.A5 sites · 441 NDC
- Hikma Pharmaceuticals USA Inc.4 sites · 763 NDC
- Jiangsu Hengrui Pharmaceuticals Co., Ltd.4 sites · 28 NDC
- AARTI PHARMALABS LIMITED3 sites · 34 NDC
- Zhejiang Hisun Pharmaceutical Co., Ltd.3 sites · 27 NDC
Enquiry
Common questions
- Is XGen Pharmaceuticals DJB, Inc. FDA approved?
- XGen Pharmaceuticals DJB, Inc. holds no registered establishment of its own; 33 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does XGen Pharmaceuticals DJB, Inc. make?
- 33 products are listed under XGen Pharmaceuticals DJB, Inc. in the openFDA NDC Directory, most often as injection, solution; injection, powder, lyophilized, for solution; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
- Are any XGen Pharmaceuticals DJB, Inc. products in shortage?
- 4 presentations are currently listed in the FDA drug shortage database under XGen Pharmaceuticals DJB, Inc., covering Promethazine Hydrochloride Injection, Rocuronium Bromide Injection.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.